Error message

Warning: strpos(): Empty needle in display_relation_by_parent() (line 1433 of /var/www/vhosts/wco-iof-esceo.org/wco-2016-21-editions/sites/all/modules/congress/congress_c_relation.inc).

Programme at a glance

Programme at a glance, Krakow

Thursday, 19 April 2018
00.01 - 23.59
WCO-IOF-ESCEO
17.30 - 19.25
WCO-IOF-ESCEO - OPENING CEREMONY
Chairpersons: Jean‑Yves Reginster, John A. Kanis
17.30
Best clinical papers published in 2017
René Rizzoli
18.30
Opening of the meeting
Welcome Cyrus Cooper (IOF President, ESCEO Vice‑President)
Invitation to the stage of Professor Edward Czerwinski, Pawel Stanczyk (Secretary of the City, Representative of Jacek Majchrowski, Mayor of the City of Krakow) and Professor Tomasz Brzostek (Dean of the Faculty of Health Sciences Jagiellonian University, Medical College) Cyrus Cooper (IOF President, ESCEO Vice‑President)
18.45
WHO Clinical Consortium on Healthy Aging : Objectives and achievements
Islene Araujo de Carvalho (World Health Organization – Geneva)
18.55
Regional discrepancies in calcium intake: the IOF global calcium map
Bess Dawson‑Hughes
19.05
Presentation of the 2018 ESCEO Medal of Excellence
John A. Kanis
19.10
Presentation of the ESCEO-IOF Herbert Fleisch Medal
John A. Kanis
19.15
Presentation of the IOF Medal of Achievement
Cyrus Cooper
19.20
Presentation of the IOF Olof Johnell Science Award
Serge Ferrari
Friday, 20 April 2018
00.01 - 23.59
WCO-IOF-ESCEO
08.00
Opening of the commercial exhibition
08.00 - 09.00
NON-SPONSORED SYMPOSIA
Meeting Room 1
Breast Cancer and Bone Health– Joint session of the Cancer And Bone Society (CABS) and the IOF
Chairpersons: Jean‑Jacques Body, Peyman Hadji
Adjuvant antiresoptive treatment in women with breast cancer - Cancer Treatment Induced Bone Loss (CTIBL) and much more Peyman Hadji
Treatment of metastatic bone disease in women with breast cancer - New insights of an old story Jean‑Jacques Body
Meeting Room 2
Sarcopenia: Problem-solving a new lifestyle disease
Chairperson: Kerrie  Sanders
Reducing the burden of sarcopenia: A healthy lifestyle throughout the lifetime David Scott
Is the risk of sarcopenia socially patterned? Sharon L. Brennan‑Olsen
Sarcopenia: is the right food the key to prevention? Sandra Iuliano‑Burns
International dialogue and problem-solving
Meeting Room 3
Bone fragility in diabetes
Chairperson: Serge Ferrari
Pathophysiology of bone fragility in diabetes Serge Ferrari
Fracture risk assessment in diabetes Emmanuel Biver
Osteoporosis drug effects in diabetics Nicola Napoli
Meeting Room 4
Treating Osteosarcopenia by Targeting Muscle and Bone: Actuality and Perspectives
Chairperson: Gustavo Duque
Combined effects of vitamin D on muscle and bone: a review of evidence among senior adults age 65+ Heike A. Bischoff‑Ferrari
Novel Exercise and Nutritional Approaches to Optimize Bone, Muscle and Mobility into Old Age Robin Daly
Pharmacological Treatment of Osteosarcopenia: How to target bone and muscle at the same time? Gustavo Duque
Meeting Room 5
Global Map of Dietary Calcium Intake reveals large geographic regions of low intake – a call to action
Chairperson: Bess Dawson‑Hughes
Introduction Bess Dawson‑Hughes
Calcium intake and its implications in India Ambrish Mithal
Calcium intake and its implications in China and the Pacific Rim Wei‑bo Xia
Discussion
08.00 - 09.00
ESCEO-WHO SYMPOSIA
Meeting Room 6
Principles for the engagement of patients in the preparation of clinical and regulatory guidelines : outcomes of an experts consensus meeting organized by the World Health Organization and the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases.
Chairpersons: Famida Jiwa, Peter Tugwell
08.00 ‣ Welcome and scope of the problem Peter Tugwell
08.05 ‣ A journey in patient partnership John Kirwan
08.15 ‣ Principles for patients engagement in the preparation of clinical guidelines Maarten de Wit
08.30 ‣ Principles for patients engagement in the preparation of regulatory guideline Nathalie Bere
08.45 ‣ Discussion - Leaders Philip Conaghan, Daniel Pinto
09.00 ‣ Conclusion Famida Jiwa
Panel: Isabelle Aujoulat, Nathalie Bere, Maria Luisa Brandi, Olivier Bruyère, Philip Conaghan, Cyrus Cooper, Maarten de Wit, Philippe Halbout, Mickaël Hiligsmann, Famida Jiwa, John A. Kanis, John Kirwan, Andrea Laslop, Daniel Pinto, Jean‑Yves Reginster, René Rizzoli, Marieke Scholte, Peter Tugwell, Lia Van der Ham, Mila Vlaskovska
Meeting Room 7
Assessment of Physical Performance in daily clinical practice: Outcomes of an Experts’ consensus meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) under the auspices of the World Health Organization
Chairpersons: Islene Araujo de Carvalho, Roger A. Fielding
08.00 ‣ Welcome Cyrus Cooper
08.05 ‣ Scope of the problem René Rizzoli
08.10 ‣ Principles for the standardization of the assessment of physical performance Alfonso Cruz Jentoft
08.25 ‣ Principles for the standardization of the assessment of muscle strength and power Laura Schaap
08.40 ‣ Discussion - Leader: Ivan Bautmans
08.55 ‣ Conclusion Stefania Maggi
Panel: Islene Araujo de Carvalho, Jürgen Bauer, Ivan Bautmans, Roberto Bernabei, Olivier Bruyère, Cyrus Cooper, Alfonso Cruz Jentoft, Bess Dawson‑Hughes, Roger A. Fielding, Jean‑Marc Kaufman, Stefania Maggi, Jean Petermans, Jean‑Yves Reginster, René Rizzoli, Yves Rolland, Laura Schaap, Daniel Uebelhart
09.00 - 12.10
Auditorium A
SCIENTIFIC SESSION I
Chairpersons: John A. Kanis, Jean‑Yves Reginster
09.00
Auditorium A
Plenary Lecture 1
Frax : 10 years later Cyrus Cooper
09.30
Auditorium A
Oral communications selected from abstracts
09.30
Auditorium A
OC1
‣ ABALOPARATIDE FOR RISK REDUCTION OF NONVERTEBRAL AND VERTEBRAL FRACTURES IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS: AN UPDATED NETWORK META-ANALYSIS
Presenting author: J.‑Y. Reginster
Authors: F. Bianic, R. Campbell, M. Martin, S. A. Williams, L. A. Fitzpatrick
09.40
Auditorium A
OC2
‣ PERSISTENT FRACTURE RISK REDUCTION WITH ABALOPARATIDE-SC FOLLOWED BY 24 MONTHS OF ALENDRONATE
Presenting author: S. Papapoulos
Authors: H. G. Bone, L. A. Fitzpatrick, B. Mitlak, M.‑Y. Hu, G. Hattersley, K. G. Saag, R. Rizzoli
09.50
Auditorium A
OC3
‣ COST-EFFECTIVENESS OF ABALOPARATIDE FOR THE TREATMENT OF POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS
Presenting author: M. Hiligsmann
Authors: S. A. Williams, L. A. Fitzpatrick, J.‑Y. Reginster
10.00
Auditorium A
OC4
‣ RESULTS FROM A 52-WEEK, PHASE 2A STUDY OF AN INTRA-ARTICULAR, WNT PATHWAY INHIBITOR, SM04690, FOR KNEE OSTEOARTHRITIS
Presenting author: J. Tambiah
Authors: N. Lane, Y. Yazici, T. McAlindon, A. Gibofsky, D. Clauw, C. Swearingen, A. Difrancesco, M. Hochberg
10.10
Auditorium A
OC5
‣ JOINT SPACE WIDTH CRITERIA CAN REDUCE KNEE OA TRIAL HETEROGENEITY: PHASE 2 POST-HOC DATA FROM WNT PATHWAY INHIBITOR, SM04690
Presenting author: P. Conaghan
Authors: J. Tambiah, C. Swearingen, S. Kennedy, M. Bowes, A. Brett, C. Lattermann
10.20
Auditorium A
Presentation of the ESCEO-AgNovos Healthcare Young Investigator Awards
Jean‑Yves Reginster
10.30
Auditorium A
Plenary Lecture 2
Bone microstructure and fracture risk: implications for the clinician? Serge Ferrari
11.00
Auditorium A
Oral Communications selected from abstracts
11.00
Auditorium A
OC6
‣ SYSTEMATIC SCREENING USING FRAX LEADS TO INCREASED USE OF, AND ADHERENCE TO, ANTI-OSTEOPOROSIS MEDICATIONS: THE UK SCOOP TRIAL
Presenting author: C. Parsons
Authors: N. C. Harvey, L. Shepstone, J. A. Kanis, E. Lenaghan, S. Clarke, R. Fordham, N. Gittoes, I. Harvey, R. Holland, A. Heawood, N. M. Redmond, A. Howe, T. Marshall, T. J. Peters, D. Torgerson, T. W. O'Neill, E. V. McCloskey, C. Cooper
11.10
Auditorium A
OC7
‣ LOCAL OSTEO-ENHANCEMENT PROCEDURE UTILIZING A NOVEL TRIPHASIC CALCIUM BASED IMPLANT INCREASES LONG TERM FEA-ESTIMATED PROXIMAL FEMUR STRENGTH IN OSTEOPOROTIC WOMEN
Presenting author: M. Bouxsein
Authors: T.  Keaveny, D. Lee, J. Stroncek, R. Hill, J. Howe, B. Huber
11.20
Auditorium A
OC8
‣ A META-ANALYSIS OF 4 CLINICAL TRIALS OF DENOSUMAB (DMAB) COMPARED WITH BISPHOSPHONATES (BPS) IN POSTMENOPAUSAL WOMEN PREVIOUSLY TREATED WITH ORAL BISPHOSPHONATES (OBPS)
Presenting author: J. Malouf
Authors: P. D. Miller, N. Pannacciulli, A. Singer, E. Czerwinski, H. G. Bone, C. Wang, R. B. Wagman, J. P. Brown
11.30
Auditorium A
OC9
‣ TEN-YEAR CONTINUED NONVERTEBRAL FRACTURE (NVFX) REDUCTION IN POSTMENOPAUSAL OSTEOPOROSIS WITH DENOSUMAB (DMAB) TREATMENT
Presenting author: S. Ferrari
Authors: P. W. Butler, D. L. Kendler, P. D. Miller, C. Roux, A. T. Wang, R. B. Wagman, E. M. Lewiecki
11.40
Auditorium A
OC10
‣ DENOSUMAB IMPROVES GLYCEMIC CONTROL OF TYPE 2 DIABETIC PATIENTS WITH OSTEOPOROSIS
Presenting author: C.K. Chew
Authors: S. Khosla, R. Rizza, J. Geske, B. Clarke
11.50
Auditorium A
OC11
‣ EVALUATION OF INVASIVE ORAL PROCEDURES AND EVENTS (OPES) IN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS (PMO) TREATED FOR UP TO 10 YEARS WITH DENOSUMAB (DMAB): RESULTS FROM THE PHASE 3 FREEDOM OPEN-LABEL EXTENSION (EXT)
Presenting author: P. W. Butler
Authors: N. B. Watts, J.T. Grbic, N. Binkley, X. Yin, A. Tierney, R. B. Wagman, M. R. McClung
12.00
Auditorium A
OC12
‣ EFFECTS OF ROMOSOZUMAB IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS AFTER 2 AND 12 MONTHS ASSESSED BY MICRO COMPUTED TOMOGRAPHY AND HISTOMORPHOMETRY ON ILIAC CREST BONE BIOPSIES
Presenting author: P. Chavassieux
Authors: R. D. Chapurlat, J.‑P. Roux, N. Portero‑Muzy, P. Garcia, J. P. Brown, S. Horlait, C. Libanati, R. Boyce, A. Wang, A. Grauer
14.00 - 15.00
MEET-THE-EXPERT SESSIONS
Meeting Room 4
Local bone treatment in osteoporosis
Andreas Kurth
Meeting Room 1
Bone fragility in young people: when and how to investigate ?
Serge Ferrari
Meeting Room 2
Hypophosphatasia, diagnosis and management
Maria Luisa Brandi
Meeting Room 3
Muscle function assessment in daily practice
Olivier Bruyère, Charlotte Beaudart
14.00 - 15.00
Poster Area
Poster Viewing Session I
14.00 - 15.17
Podium
Oral presentation of selected posters
Chairperson: Fanny Buckinx
14.00
Podium
P656
‣ SERUM CTX PREDICTS HIP FRACTURE RISK INDEPENDENTLY OF FRAX (WITHOUT BMD) BUT NOT OF BMD – A POST HOC ANALYSIS FROM THE SHEFFIELD HIP FRACTURE STUDY
Presenting author: E. V. McCloskey
Authors: H. Johansson, A. Oden, N. C. Harvey, R. Eastell, F. Gossiel, J. A. Kanis
14.07
Podium
P153
‣ DIETARY PROTEIN INTAKE ABOVE THE CURRENT RDA AND BONE HEALTH: A SYSTEMATIC REVIEW AND META-ANALYSIS
Presenting author: T. C. Wallace
Author: C. L. Frankenfeld
14.14
Podium
P188
‣ INCREASED MORTALITY RISK IN MEN WITH HIGH DIETARY CALCIUM INTAKE BUT NOT IN WOMEN
Presenting author: A. J. Rodriguez
Authors: D. Scott, B.  Khan, A. Hodge, D. R. English, G. G. Giles, B. Abrahamsen, P. R. Ebeling
14.21
Podium
P701
‣ ASSOCIATIONS BETWEEN RADIUS LOW-FREQUENCY AXIAL ULTRASOUND VELOCITY AND BONE FRAGILITY IN ELDERLY MEN AND WOMEN
Presenting author: E. Biver
Authors: J. Pepe, A. De Sire, T. Chevalley, S. Ferrari
14.28
Podium
P510
‣ VITAMIN D STATUS IN ADOLESCENCE IS AN INDEPENDENT PREDICTOR OF BONE MINERAL DENSITY AND MICROARCHITECTURE IN EARLY ADULTHOOD: A 17-YR PROSPECTIVE COHORT STUDY
Presenting author: Y. Yang
Authors: F. Wu, T. Winzenberg, G. Jones
14.35
Podium
P308
‣ BUROSUMAB, AN ANTI-FGF23 MONOCLONAL ANTIBODY, FOR X-LINKED HYPOPHOSPHATEMIA (XLH): ANALYSIS BY AGE FROM TWO PHASE 2 PEDIATRIC TRIALS
Presenting author: R. Padidela
Authors: T. O. Carpenter, E. A. Imel, A. A. Portale, A. Linglart, W. Högler, A. Boot, W. van't Hoff, G. S. Gottesman, M. Mao, A. Skrinar, J. San Martin, M. P. Whyte
14.42
Podium
P1065
‣ INTERVENTION THRESHOLD BASED ON FRAX AND BMD
Presenting author: H. Johansson
Authors: F. Azizieh, N. Al Ali, A. Thamer, N. C. Harvey, E. V. McCloskey, J. Kanis
14.49
Podium
P195
‣ IMPACT OF BISPHOSPHONATES IN AGE-RELATED MACULAR DEGENERATION: RETROSPECTIVE COHORT AND NESTED CASE-CONTROL STUDY
Presenting author: C. Garriga
Authors: M. Pazianas, S. Hawley, A. Delmestri, D. Prieto‑Alhambra, C. Cooper, A. Judge
14.56
Podium
P473
‣ POCOSTEO: POC IN-OFFICE DEVICE FOR IDENTIFYING INDIVIDUALS AT HIGH RISK OF OSTEOPOROSIS AND OSTEOPOROTIC FRACTURE
Presenting author: P. Khashayar
Authors: F. Leys, P. Lopes, A. Ostovar, G. Schols, R. Gransee, D. Latta, P. Biggs, I. J. Riley, C. K. O'Sullivan, I. Katakis, M. Ortiz, J. L. L. Acero, R. Hoogenboom, F. Devlieghere, P. Ragaert, B. Barredo, M. Adriaens, B. Obermayer‑Pietsch, H. P. Dimai, B. Larijani, J. Vanfleteren
15.03
Podium
P524
‣ ANTI-OSTEOPOROSIS MEDICATION PRESCRIPTIONS AND INCIDENCE OF SECONDARY FRACTURE AMONGST HIP FRACTURE PATIENTS IN ENGLAND AND WALES: AN AGE STRATIFIED INTERRUPTED TIME SERIES ANALYSIS
Presenting author: S. Hawley
Authors: D. Prieto‑Alhambra, A. Delmestri, N. K. Arden, C. Cooper, A. Judge, M. K. Javaid
15.10
Podium
P443
‣ FRAME STUDY: THE FOUNDATION EFFECT OF REBUILDING BONE WITH ONE YEAR OF ROMOSOZUMAB LEADS TO CONTINUED LOWER FRACTURE RISK AFTER TRANSITION TO DENOSUMAB
Presenting author: S. Ferrari
Authors: F. Cosman, D. B. Crittenden, A. Khan, N. E. Lane, K. Lippuner, T. Matsumoto, C. E. Milmont, C. Libanati, A. Grauer
14.00 - 15.00
Meeting Room 6
IOF-ESCEO SYMPOSIUM
Meeting Room 6
Nutrition and physical activity in the prevention and treatment of sarcopenia: Outcomes of the IOF-ESCEO sarcopenia Working Groups
Chairpersons: Charlotte Beaudart, Elaine M. Dennison
14.00 ‣ Welcome and scope of the problem Nicholas Harvey
14.05 ‣ Methodology of the systematic review Elaine M. Dennison
14.15 ‣ Outcomes of the systematic review Charlotte Beaudart
14.25 ‣ Dairy products in the prevention and treatment of sarcopenia: Outcomes of the ESCEO Working Groups Jean‑Yves Reginster
14.40 ‣ Discussion - Leader: Roland D. Chapurlat
14.55 ‣ Conclusion Charlotte Beaudart

This Symposium was made possible through an Unrestricted Educational Grant from the “European Milk Forum” (EMF) and the “Centre de recherche et d’information nutritionnelles” (CERIN)

15.00 - 16.45
Meeting Room 6
COMMITTEE OF NATIONAL SOCIETIES SPECIAL PLENARY SESSION
‣ Clinical, social, ethical and economic burden of osteoporosis and fragility fractures
Chairperson: Jean‑Yves Reginster
15.03
Meeting Room 6
OCs1
‣ ONE YEAR OUTCOMES OF FRACTURE LIAISON SERVICE AT THE NATIONAL TAIWAN UNIVERSITY HEALTHCARE SYSTEM
Presenting author: D.‑C. Chan
Authors: R.‑S. Yang, C.‑H. Hong, K.‑S. Tsai
15.11
Meeting Room 6
OCs2
‣ RELATIONSHIPS OF PLASMA TOTAL HOMOCYSTEINE, FOLATE AND VITAMIN B12 LEVELS TO VERTEBRAL FRACTURE AND BONE MINERAL DENSITY IN MOROCCAN HEALTHY POSTMENOPAUSAL WOMEN
Presenting author: A. El Maataoui
Authors: S. Nadifi, A. El Maghraoui, Z. Ouzzif
15.19
Meeting Room 6
OCs3
‣ SARCOPENIA AND QUALITY OF LIFE QUESTIONNAIRE (SARQOL®): GREEK CROSS CULTURAL ADAPTATION
Presenting author: C. Matzaroglou
Authors: M. Tsekoura, E. Billis, J. Gliatis, E. Tsepis, G.K. Sakkas, C. Beaudart, O. Bruyère, E. Panagiotopoulos
15.27
Meeting Room 6
OCs4
‣ FRAILTY AND RISK OF FRAGILITY FRACTURES IN PARTICIPANTS WITH TYPE 2 DIABETES MELLITUS
Presenting author: G. Li
Authors: J. Prior, A. Papaioannou, L. Thabane, M. Levine, J. Adachi
15.35
Meeting Room 6
OCs5
‣ DIETARY CALCIUM INTAKE IN CAUCASIAN AND EAST ASIAN ADOLESCENTS: A STUDY OF EXPATRIATE MALE HIGH SCHOOLERS AGED 16-18 YEARS RESIDING IN SINGAPORE
Presenting author: M. Chandran
Author: A.D. Chandran
15.43
Meeting Room 6
OCs6
‣ THE ORGANIZATION OF SECONDARY FRACTURE PREVENTION SERVICES IN RUSSIAN FEDERATION
Presenting author: O.  Lesnyak
Authors: K. Belova, O. Ershova
15.51
Meeting Room 6
OCs7
‣ ASSOCIATION BETWEEN OSTEOPOROSIS AND COGNITIVE IMPAIRMENT IN A COMMUNITY DWELLING OLDER POPULATION
Presenting author: F. Sharifi
Authors: G. Shafiee, R. Heshmat, I. Nabipour, B. Larijani, A. Ostovar
15.59
Meeting Room 6
OCs8
‣ VERTEBRAL FRACTURES CASCADE: POTENTIAL ETIOLOGIES AND RISK
Presenting author: H. Che
Authors: V. Breuil, B. Cortet, J. Paccou, L. Chapuis, F. Debiais, R. M. Javier, N. Mehsen Cetre, T. Thomas, C. Roux, K. Briot, S. Loiseau Peres
16.07
Meeting Room 6
OCs9
‣ PREVALENCE OF OSTEOPOROSIS IN THE TURKISH WOMEN, RISK FACTORS AND THEIR AWARENESS ABOUT OSTEOPOROSIS ACCORDING TO THE CAMPAIGN OF “HEALTHY BONES & STRONG WOMEN”
Presenting author: Y. Kirazli
Authors: F.C. Atamaz Calis, S. Tuzun, O. El, O. Peker, B. Durmaz, S. Oncel
16.15
Meeting Room 6
OCs10
‣ TRABECULAR BONE SCORE OF CHILDREN AND ADOLESCENTS 4 TO 19 YEARS OLD IN MEXICO CITY
Presenting author: M. A. Guagnelli
Authors: R. Ambrosi, D. Lopez‑Gonzalez, R. Winzenrieth, L. Del Rio, P. Clark
16.23
Meeting Room 6
OCs11
‣ CROSS CULTURAL ADAPTATION OF THE SARQOL QUESTIONNAIRE INTO HUNGARIAN LANGUAGE
Presenting author: A. I. Gasparik
Author: L. Hodinka
16.35
Meeting Room 6
Presentation of the IOF Committee of National Societies Medal
Jean‑Yves Reginster
15.00 - 17.00
Auditorium A
SCIENTIFIC SESSION II
Chairpersons: Cyrus Cooper, Olivier Bruyère
15.00
Auditorium A
Plenary Lecture 3
New perspectives in osteoarthritis management Philip Conaghan
15.30
Auditorium A
Presentation of the IOF President's Award
Cyrus Cooper
15.35
Auditorium A
Presentation of the ESCEO-IBSA Best Oral Presentation Award
Olivier Bruyère
15.35
Auditorium A
Presentation of the ESCEO-IBSA Young Investigator Award
Cyrus Cooper
15.40
Auditorium A
Oral communications selected from abstracts
15.40
Auditorium A
OC13
‣ A PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY INVESTIGATING THE EFFICACY AND SAFETY OF BUROSUMAB, AN ANTI-FGF23 ANTIBODY, IN ADULT X-LINKED HYPOPHOSPHATEMIA (XLH)
Presenting author: P. Kamenicky
Authors: R. Lachmann, T. O. Carpenter, M. Cohen‑Solal, R. Eastell, M. L. Brandi, R.K. Crowley, S.H. Ralston, K. Javaid, R. Keen, K. Briot, H. I. Cheong, Y. Imanishi, N. Ito, H. Tanaka, J. Zhang, C. Theodore‑Oklota, M. Mealiffe, J. San Martin, K. Insogna
15.50
Auditorium A
OC14
‣ EFFECTS OF RESISTANCE AND IMPACT EXERCISE TRAINING ON TRABECULAR BONE MICROARCHITECTURE AND KNEE CARTILAGE HEALTH IN OLDER ADULTS: AN 18-MONTH RANDOMIZED CONTROLLED TRIAL
Presenting author: R.M. Daly
Authors: J. Gianoudis, M.E. Kersh, Y. Wang, C.A. Bailey, P. R. Ebeling, C.A. Nowson, K. Sanders, F. Cicuttini, K.D. Hill
16.10
Auditorium A
OC16
‣ EFFECT OF LACTOBACILLUS REUTERI ON BONE LOSS IN OLDER WOMEN WITH LOW BONE MINERAL DENSITY – A RANDOMIZED CLINICAL TRIAL
Presenting author: M. Lorentzon
Authors: G. Nilsson, D. Sundh, F. Bäckhed
16.20
Auditorium A
OC17
‣ MORE FREQUENT AND MORE SUSTAIN OSTEOPOROSIS TREATMENT AFTER FRAGILITY VERTEBRAL FRACTURES WHEN INTRODUCED EARLY IN INPATIENTS THAN DELAYED IN OUTPATIENTS
Presenting author: T. Chevalley
Authors: H. Spechbach, I. Fabreguet, E. Saule, M. Hars, J. Stirnemann, S. Ferrari, R. Rizzoli
16.30
Auditorium A
Plenary Lecture 4
Management of iatrogenic osteoporosis Peyman Hadji
Saturday, 21 April 2018
00.01 - 23.59
WCO-IOF-ESCEO
08.00 - 09.00
NON-SPONSORED SYMPOSIA
Meeting Room 1
Complex Regional Pain Syndrome: Facts on Causes, Diagnosis and Therapy
Chairperson: Maria Luisa Brandi
Introduction Maria Luisa Brandi
Definition of the Complex Regional Pain Syndrome Giovanni Iolascon
Therapies for the Complex Regional Pain Syndrome Giovanni Orsolini
Conclusion
Meeting Room 2
Achieving gender equity in musculoskeletal science - why it matters and how can we do it ?
Chairperson: Christel Lamberg‑Allardt
The effects of equity and diversity on research impact: narrative review of the literature Christel Lamberg‑Allardt
Advance Australia Fair: progress in gender equity in science in Australia Tania Winzenberg
Practical initiatives to support gender equity in science Sharon L. Brennan‑Olsen
Meeting Room 3
Demonstrating fracture liaison service effectiveness - Use of fracture incidence and prescribing data to demonstrate clinical and cost effectiveness in a small population
Chairperson: Kassim Javaid
Preventing disability and ageing well: an innovative service support model for fracture prevention in the UK Debbie Stone
Making the case for fracture liaison services in prevention of disability – analysis of national prescribing data in England Tim Jones
Meeting Room 4
Mediterranean diet and muscoloskeletal diseases
Chairpersons: Gaetano Crepaldi, René Rizzoli
Introduction
Mediterranean diet and bone health Stefania Maggi
Mediterranean diet and muscular function Matteo Tosato
Mediterranean diet and osteoarthritis Nicola Veronese
Discussion
Meeting Room 5
DO-HEALTH: First results of a large European Trial
Chairperson: John A. Kanis
Introduction John A. Kanis
Review results of recent trials involving supplemental vitamin D and musculoskeletal outcomes Bess Dawson‑Hughes
First presentation of trial findings of DO-HEALTH regarding musculoskeletal outcomes. Heike A. Bischoff‑Ferrari
Meeting Room 7
ASBMR-IOF-ESCEO Symposium: Closing the Treatment Gap
Chairperson: Cyrus Cooper
An update on fracture liaison implementation and quality measures in the US Robert Adler
A strategic roadmap and action plan to prevent secondary fractures Douglas Kiel
A global overview of secondary fracture prevention strategies and service initiatives worldwide Nicholas Harvey
An update on risk assessment and fracture prevention in European nations Eugene McCloskey
08.00 - 09.00
Meeting Room 6
Joint ESPRM – ESCEO – IOF Symposium
Meeting Room 6
Role of Physical Medicine and Rehabilitation in the Management of Osteoporosis and Musculoskeletal Disorders
Maria Staniszewska
The effect of exercise on pain and functional activity in knee osteoarthritis Fitnat Dincer
The role of rehabilitation in prevention and treatment of Spinal Disorders Piotr Tederko
Chairperson: Fitnat Dincer
09.00 - 12.10
Auditorium A
SCIENTIFIC SESSION III
Chairpersons: Bess Dawson‑Hughes, Alfonso Cruz Jentoft
09.00
Auditorium A
Plenary Lecture 5
Inflammation and musculoskeletal aging Eugene McCloskey
09.30
Auditorium A
Oral communications selected from abstracts
09.30
Auditorium A
OC18
‣ PHYSICAL ACTIVITY PHENOTYPES ARE ASSOCIATED WITH CARTILAGE VOLUME LOSS AND KNEE REPLACEMENT, BUT NOT WITH INCIDENT BONE-MARROW LESIONS OVER 10.7 YEARS
Presenting author: I. P. Munugoda
Authors: F. Pan, K. Wills, F. Cicuttini, S.E. Graves, M. Lorimer, G. Jones, M.L. Callisaya, D. Aitken
09.40
Auditorium A
OC19
‣ ASSOCIATION BETWEEN DIETARY NUTRIENT INTAKE AND SARCOPENIA: THE SARCOPHAGE COHORT STUDY
Presenting author: C. Beaudart
Authors: M. Locquet, M. Touvier, J.‑Y. Reginster, O. Bruyère
09.50
Auditorium A
OC20
‣ THE FRAILTOOLS STUDY - A COMPREHENSIVE VALIDATION OF TOOLS TO SCREEN AND DIAGNOSE FRAILTY IN DIFFERENT CLINICAL AND SOCIAL SETTINGS
Presenting author: T. Grodzicki
Authors: A. Parnicka, A. Kańtoch, B. Wizner, B. Gryglewska, M. Checa, J. Carnicero, S. Bellary, B. Vellas, M. Cesari, R. Bernabei, F. Landi, L.R. Mañas
10.00
Auditorium A
OC21
‣ TRANSLATING THE LIFESTYLE INTERVENTIONS AND INDEPENDENCE FOR ELDERS CLINICAL TRIAL TO MOBILITY-LIMITED OLDER ADULTS IN THE COMMUNITY: THE ENGAGE PILOT STUDY
Presenting author: K. Reid
Authors: J. Laussen, K. Bhatia, D. Englund, D. Kirn, I. Price, T. Manini, C. Liu, C. Kowaleski, R. A. Fielding
10.10
Auditorium A
OC22
‣ DYNAMIC APPROACH OF THE FRAILTY STATUS IN NURSING HOMES: 2-YEAR PROSPECTIVE FOLLOW-UP OF THE SENIOR COHORT
Presenting author: F. Buckinx
Authors: A. Charles, X. Rygaert, J.‑Y. Reginster, J. Petermans, O. Bruyère
10.20
Auditorium A
Presentation of the ESCEO-IOF-ERAB Scholarship
René Rizzoli
10.30
Auditorium A
Plenary Lecture 6
New perspectives in frailty and sarcopenia management Matteo Tosato
11.00
Auditorium A
Oral communications selected from abstracts
11.00
Auditorium A
OC23
‣ RELATIONSHIPS BETWEEN MUSCLE SIZE, STRENGTH AND FUNCTION AND THE RISK OF FALLS AND FRACTURES: FINDINGS FROM THE HERTFORDSHIRE COHORT STUDY
Presenting author: N. R. Fuggle
Authors: K. A. Jameson, M. H. Edwards, E. M. Dennison, C. Cooper
11.10
Auditorium A
OC24
‣ THREE-YEAR ADVERSE HEALTH CONSEQUENCES OF SARCOPENIA IN COMMUNITY-DWELLING OLDER ADULTS: RESULTS FROM THE SARCOPHAGE COHORT STUDY
Presenting author: M. Locquet
Authors: C. Beaudart, J.‑Y. Reginster, J. Petermans, O. Bruyère
11.20
Auditorium A
OC25
‣ THE DISCRIMINATIVE ABILITY OF SARQOL® ACCORDING TO THE DEFINITION OF SARCOPENIA : THE OFELY STUDY
Presenting author: E. Sornay‑Rendu
Authors: C. Beaudart, O. Bruyère, R. D. Chapurlat
11.30
Auditorium A
OC26
‣ LONG-TERM COST-EFFECTIVENESS OF SCREENING FOR FRACTURE RISK IN A UK PRIMARY CARE SETTING
Presenting author: F. Borgström
Authors: E. Jonsson, N. C. Harvey, L. Shepstone, E. Lenaghan, S. Clarke, N. Gittoes, I. Harvey, R. Holland, A. Heawood, N. M. Redmond, A. Howe, T. Marshall, T. J. Peters, D. Torgerson, T. W. O'Neill, E. V. McCloskey, C. Cooper, J. A. Kanis
11.40
Auditorium A
OC27
‣ COST-BENEFIT ANALYSIS OF CALCIUM AND VITAMIN D SUPPLEMENTS
Presenting author: H. A. Bischoff‑Ferrari
Authors: C. Weaver, C. Shanahan
11.50
Auditorium A
OC28
‣ PHYSICAL PERFORMANCE OR FUNCTION, BUT NOT APPENDICULAR LEAN MASS, PREDICT INCIDENT FRACTURES INDEPENDENTLY OF FRAX PROBABILITY AND BMD: RESULTS FROM THE OSTEOPOROTIC FRACTURES IN MEN (MROS) COHORT
Presenting author: N. C. Harvey
Authors: A. Odén, E. Orwoll, J. Lapidus, T. Kwok, M. Karlsson, B. E. Rosengren, O. Ljunggren, C. Cooper, P. M. Cawthon, J. A. Kanis, C. Ohlsson, D. Mellström, H. Johansson, E. V. McCloskey
12.00
Auditorium A
OC29
‣ PLASMA CTX IN PREGNANCY IS ALTERED BY CHOLECALCIFEROL SUPPLEMENTATION AND IS ASSOCIATED WITH MATERNAL BONE INDICES: THE MAVIDOS TRIAL
Presenting author: E. M.  Curtis
Authors: K. Maslin, S. D'angelo, R. J. Moon, S. R. Crozier, F. Gossiel, N. J. Bishop, S. Kennedy, A. T. Papageorghiou, R. Fraser, S. V. Gandhi, A. Prentice, H. M. Inskip, K. M. Godfrey, I. Schoenmakers, M. K. Javaid, R. Eastell, C. Cooper, N. C. Harvey
14.00 - 15.00
MEET-THE-EXPERT SESSIONS
Meeting Room 4
Sound use of bone turnover markers
Etienne Cavalier
Meeting Room 1
Interaction of nutrition and exercise on bone and muscle
Elaine M. Dennison
Meeting Room 2
Calcium : what is good and what is bad
Nicholas Harvey
Meeting Room 3
HIV and bone
Emmanuel Biver
Meeting Room 5
Bone microstructure and fracture prediction
Roland D. Chapurlat
14.00 - 15.00
Meeting Room 6
Educational Session jointly organized by EUGMS-ESCEO and IOF
Meeting Room 6
Managing complex older patients: beyond the bone and muscle
Chairpersons: Alfonso Cruz Jentoft, Stefania Maggi
14.00 ‣ Welcome Stefania Maggi
14.05 ‣ Assessing older complex patients (Core Geriatric Assessment for non-geriatricians) Alfonso Cruz Jentoft
14.20 ‣ Understanding and measuring co-morbidity in older people Finbarr Martin
14.35 ‣ Decision-making in complex older patients Stefania Maggi
14.50 ‣ Discussion - Leader Alfonso Cruz Jentoft
14.00 - 15.00
Poster Area
Poster Viewing Session II
14.00 - 15.10
Podium
Oral presentation of selected posters
Chairperson: Fanny Buckinx
14.00
Podium
P616
‣ STATINS AND INCIDENT KNEE OSTEOARTHRITIS: RESULTS FROM THE OSTEOARTHRITIS INITIATIVE
Presenting author: N. Veronese
Authors: S. Maggi, C. Cooper, J.‑Y. Reginster
14.07
Podium
P378
‣ COMBINED FRACTAL- AND ENTROPY-BASED ANALYSIS OF BONE TEXTURE PREDICTS INCIDENT OSTEOARTHRITIS OF THE KNEE: DATA FROM THE MULTICENTER OSTEOARTHRITIS STUDY (MOST).
Presenting author: R. Ljuhar
Authors: Z. Bertalan, S. Nehrer, D. Ljuhar, A. Fahrleitner‑Pammer, H. P. Dimai
14.14
Podium
P379
‣ RISK OF SEVERE LUMBAR SPINAL STENOSIS ON MRI SCANS IS INCREASED BY HEAVY MANUAL WORK: THE WAKAYAMA SPINE STUDY
Presenting author: Y. Ishimoto
Authors: C. Cooper, K. Walker‑Bone, G. Ntani, H. Yamada, H. Hashizume, K. Nagata, S. Muraki, S. Tanaka, N. Yoshimura, M. Yoshida
14.21
Podium
P1112
‣ A NEW DECISION TREE FOR DIAGNOSIS AND MANAGEMENT OF OSTEOARTHRITIS IN PRIMARY CARE: INTERNATIONAL CONSENSUS OF EXPERTS
Presenting author: J. Martel‑Pelletier
Authors: F. Rannou, J.‑P. Pelletier, O. Mkinsi, J. Branco, L. Alekseeva, P. Monod, F. Planta, E. Maheu, J.‑Y. Reginster
14.28
Podium
P103
‣ EFFECT OF HIGH-INTENSITY INTERVAL OR MODERATE-INTENSITY CONTINUOUS TRAINING ON BODY COMPOSTION AND PHYSICAL PERFORMANCE IN OBESE-OSTEOPENIC ELDERLY WOMEN
Presenting author: P. Noirez
Authors: M. Dulac, L.P. Carvalho, G. El Haj Boutros, V. Marcangeli, P. Gaudreau, J. A. Morais, G. Gouspillou, M. Aubertin‑Leheudre
14.35
Podium
P543
‣ PATIENT’S ENGAGEMENT IN THE IDENTIFICATION OF CRITICAL OUTCOMES IN SARCOPENIA
Presenting author: C. Beaudart
Authors: O. Bruyère, J.‑Y. Reginster, J. Bauer, C. Cooper, A. J. Cruz Jentoft, F. Landi, M. Locquet, S. Maggi, R. Rizzoli, Y. Rolland, N. Vaquero, M. Hiligsmann
14.42
Podium
P640
‣ HIGH POSTURAL SWAY PREDICTS FRACTURES IN ELDERLY WOMEN
Presenting author: S. L. Qazi
Authors: J. Sirola, H. Kröger, R. Honkanen, M. Isanejad, O. Airaksinen, T. Rikkonen
14.49
Podium
P876
‣ EFFICACY OF DIFFERENT MODES OF VITAMIN D SUPPLEMENTATION STRATEGIES IN SAUDI ADOLESCENTS
Presenting author: N. Al‑Daghri
Authors: M. Ansari, S. Sabico, Y. Al‑Saleh, N. Aljohani, H. Alfawaz, M. Alharbi, A. Al‑Othman, M. Alokail, S. Wimalawansa
14.56
Podium
P646
‣ LOW BONE MINERAL DENSITY AND RISK OF FALLS ARE INCREASED AMONG INDIVIDUALS WITH RHEUMATOID ARTHRITIS: FINDINGS FROM UK BIOBANK
Presenting author: M. A. Clynes
Authors: K. A. Jameson, D. Prieto‑Alhambra, N. C. Harvey, C. Cooper, E. M. Dennison
15.03
Podium
P637
‣ THIRTY-ONE MEN AND WOMEN WITH 145 SPONTANEOUS VERTEBRAL FRACTURES AFTER DENOSUMAB DISCONTINUATION: A SINGLE CENTER OBSERVATIONAL STUDY
Presenting author: E. Gonzalez‑Rodriguez
Authors: D. Stoll, B. Aubry‑Rozier, O. Lamy
14.00 - 15.00
Meeting Room 7
ESCEO SYMPOSIUM
Meeting Room 7
Guidelines for the conduct of clinical trials in hand osteoarthritis
Chairpersons: Cyrus Cooper, Andrea Laslop
14.00 ‣ Introduction and scope of the problem Nigel K. Arden
14.10 ‣ Guidelines for the conduct of pharmacological trials in hand OA : Consensus of a working group of the ESCEO Ida Haugen
14.30 ‣ Discussion All
14.55 ‣ Conclusion Andrea Laslop
Panel: Nigel K. Arden, Jaime Branco, Olivier Bruyère, Etienne Cavalier, Roland D. Chapurlat, Cyrus Cooper, Elaine M. Dennison, Ida Haugen, Gabriel Herrero‑Beaumont, Andrea Laslop, Stefania Maggi, Ouafa Mkinsi, Daniel Prieto‑Alhambra, Jean‑Yves Reginster, François Rannou, Thierry Thomas, Daniel Uebelhart, Nicola Veronese
15.00 - 17.00
Auditorium A
SCIENTIFIC SESSION IV
Chairpersons: Serge Ferrari, Nicholas Harvey
15.00
Auditorium A
Plenary Lecture 7
Microbiota and bone disease René Rizzoli
15.35
Auditorium A
Presentation of the IOF Best Committee of National Societies Booth
Jean‑Yves Reginster, Philippe Halbout
15.40
Auditorium A
Oral communications selected from abstracts
15.40
Auditorium A
OC30
‣ RISK OF INCIDENT FRACTURE IS ASSOCIATED WITH DOSE, DURATION AND RECENCY OF ORAL GLUCOCORTICOID EXPOSURE
Presenting author: D. E. Robinson
Authors: T. P. Van Staa, M. Lunt, E. M. Dennison, C. Cooper, W.G. Dixon
15.50
Auditorium A
OC31
‣ PRO-INFLAMMATORY DIETARY PATTERN IS ASSOCIATED WITH FRACTURES IN WOMEN: AN EIGHT YEAR LONGITUDINAL COHORT STUDY
Presenting author: N. Veronese
Authors: N. Shivappa, J. Hebert, C. Cooper, G. Guglielmi, J.‑Y. Reginster, R. Rizzoli, S. Maggi
16.00
Auditorium A
OC32
‣ LONG-TERM EFFECTS ON BONE MINERAL DENSITY AFTER FOUR YEARS OF TREATMENT WITH TWO INTENSIVE COMBINATION STRATEGIES, INCLUDING INITIALLY HIGH DOSE PREDNISOLONE, IN EARLY RHEUMATOID ARTHRITIS PATIENTS: THE COBRA-LIGHT TRIAL.
Presenting author: M. J. J. Lucassen
Authors: M.M. Ter Wee, D. Den Uyl, N.P.C. Konijn, M.T. Nurmohamed, D. van Schaardenburg, P.J.S. Kerstens, I.E.M. Bultink, L.H.D. van Tuyl, M. Boers, W. F. Lems
16.10
Auditorium A
OC33
‣ UTILITY LOSS AFTER A SENTINEL FRACTURE
Presenting author: H. Johansson
Authors: J. Kanis, A. Odén, N. C. Harvey, V. Gudnason, K. Sanders, G. Sigurdsson, K. Siggeirsdottir, L. A. Fitzpatrick, M. Lorentzon, F. Borgström, E. V. McCloskey
16.20
Auditorium A
OC34
‣ DANGER OF OVERTREATMENT OF OSTEOPOROSIS WITH INAPPROPRIATE USE OF INTERVENTION THRESHOLDS DERIVED BY COST-EFFECTIVENESS ANALYSIS
Presenting author: E. V. McCloskey
Authors: H. Johansson, A. Oden, N. C. Harvey, J. Compston, C. Cooper, J. A. Kanis
16.30
Auditorium A
Plenary Lecture 8
Obesity, osteoporosis diagnosis and fracture risk Peter R. Ebeling
18.30 - 19.30
NON-SPONSORED SYMPOSIA
Meeting Room 1
Clinical Application of Bone Markers
Chairpersons: Richard Eastell, Adolfo Diez‑Perez
Methodological conditions for testing PINP and CTX. NBHA recommendations. Pawel Szulc
Assay Standardisation. Report of the IOF/IFCC Bone Turnover Marker Working Group. Etienne Cavalier
Recommendations for the practice. IOF/ECTS Adherence Working Group recommendations Adolfo Diez‑Perez
Recommendations for the practice. IOF/ECTS Adherence Working Group recommendations Richard Eastell
Meeting Room 0
Joint IOF ESCEO FFN Secondary Fracture Prevention / FLS
Chairperson: Kristina Åkesson
Challenges of FLS - Global perspective & Results of Survey Kassim Javaid
Integration with Trauma Frede Frihagen
Tools from the CtF programme Thierry Thomas
Discussion
Meeting Room 3
Management of Bone Health Throughout Women's Life Span. Gynecological Perspective on Effective Prevention of Osteoporosis Fragility Fracture
Chairperson: Adriana Orcesi Pedro
Opening Adriana Orcesi Pedro
Epidemiology and risk factors for osteoporosis in women. Bruno Muzzi Camargos
Update on hormone therapy and osteoporosis prevention Adriana Orcesi Pedro
Osteoporosis prevention and treatment on special situations during women´s life span Ben‑Hur Albergaria
Question & Answers with audience
Meeting Room 7
Optimising bone health, muscle strength and balance in middle-aged women: new opportunities for long-term fracture prevention
Chairpersons: Tania Winzenberg, Christel Lamberg‑Allardt
Targets for optimising bone, muscle strength and balance in middle-aged women Feitong Wu
The role of dietary phosphorus in bone health in middle-aged adults Christel Lamberg‑Allardt
Is bone density testing an under-utilised educational tool in younger women? Tania Winzenberg
Meeting Room 5
Musculo-skeletal Imaging by clinical microCT
Chairpersons: Roland D. Chapurlat, Eric Lespessailles
Introduction “Contribution of HRpQCT to the management of bone and joint diseases” Roland D. Charpulart, Eric Lespessailles
What does HRpQCT investigation have added to the field of osteoporosis ? Serge Ferrari
What does HRpQCT investigation have added to the field of chronic inflammatory rheumatisms ? Stephanie Finzel
Questions & Answers All
Meeting Room 6
A contemporary approach in education: Developing the role of nurses working in secondary fracture prevention
Chairperson: Kassim Javaid
The role of the fracture liaison nurse Sonya Stephenson
Competency framework for health professionals working in fracture prevention Debbie Stone
18.40 - 19.40
Cocktail offered by ESCEO and IOF to all recipients of prizes, awards, fellowships and scholarships - by invitation only
Sunday, 22 April 2018
00.01 - 23.59
WCO-IOF-ESCEO
08.00 - 09.00
NON-SPONSORED SYMPOSIA
Meeting Room 1
Taking care of the osteoporotic spine
Chairpersons: Sansin Tüzün, Radmila Matijevic
The Impact of spinal alignment on falls and fractures Ülkü Akarirmak
How to create a stable spine via exercise in osteoporosis? Sansin Tüzün
To brace or not to brace in the osteoporotic spine? Füsun Güler  Uysal
Spinal Augmentation: How to choose the best candidate? Çağatay Öztürk
Meeting Room 2
Optimalisation of Fracture Liaison Services
Chairpersons: Willem Lems, Kassim Javaid
The Capture the Fracture Project, a flagship of IOF Kristina Åkesson
A database of > 200 FLS services, what can we learn from that? Kassim Javaid
In patients in which a DXA is indicated, a VFA (vertebral fracture assessment) is also indicated! Willem Lems
Discussion
Meeting Room 4
Impact of osteoporosis/osteopenia in management of osteoarthritis
Chairperson: Hannu T. Aro
The prevalence of osteoporosis and vitamin-D deficiency in patients with hip osteoarthritis Julie Glowacki
Selection of uncemented or cemented hip prosthesis in fracture patients and osteoarthritic patients: implant stability, periprosthetic bone loss and periprosthetic fractures Olof Sköldenberg
Zoledronic acid and denosumab in prevention of periprosthetic bone loss in cementless hip replacement of postmenopausal women Hannu T. Aro
Meeting Room 5
Novelty regarding the potential of nutritional interventional studies with or without exercise training to prevent muscle function in older adults
Chairpersons: Mylène Aubertin‑Leheudre, Olivier Bruyère
Vitamin D and muscle function Olivier Bruyère
Omega-3 and muscle function Yves Rolland
Citruline and muscle function Mylène Aubertin‑Leheudre
Meeting Room 7
Management of Osteoporosis - Closing the gap in the CEE countries
Chairperson: Heinrich Resch
Fracture epidemiology in the CEE countries Peter Lakatos
Closing the treatment gap in Poland - our experiences Edward Czerwinski
The add value of Biomarkers Vladimir Palicka
Simple but accurate tools in the fracture risk assessment Catalina Poiana
Treatment failures and side effects Juray Payer
Meeting Room 3
Diabetes and Osteoporosis: A sweet relationship
Chairperson: Bruno Muzzi Camargos
Underlying mechanisms between diabetes mellitus and osteoporosis Oscar Rosero Olarte
Bone microarchitecture in diabetes Maria Belen Zanchetta
Fracture risk assessment on diabetic patients: FRAX, DXA, TBS Bruno Muzzi Camargos
Osteoporosis treatment on diabetic patients: Efficacy and drug interactions Adriana Medina Orjuella
Clinical guidance: Diabetic patients at risk of fractures Luis Fernando Vidal Neira
Questions and answers All
08.00 - 09.00
Meeting Room 6
ESCEO SYMPOSIUM
Meeting Room 6
Phosphate wasting disorders: What the bone doctor should know. A report of an ESCEO Working Group.
Chairpersons: Maria Luisa Brandi, René Rizzoli
08.00 ‣ The FGF23/Phosphate/Klotho/FGF-Rs machinery Dieter Haffner
08.15 ‣ Expression of Phosphate Wasting Disorders in the Adults Kassim Javaid
08.30 ‣ Management of Phosphate Wasting Disorders Laura Masi
08.45 ‣ Discussion
08.55 ‣ Conclusions Serge Ferrari
Panel: Maria Luisa Brandi, René Rizzoli, Dieter Haffner, Kassim Javaid, Laura Masi, Serge Ferrari, Peter Kamenicky
09.00 - 10.00
MEET-THE-EXPERT SESSIONS
Meeting Room 2
Intra-articular therapy in knee osteoarthritis
François Rannou
Meeting Room 1
Vitamin D : What is good and what is bad
Bess Dawson‑Hughes
Meeting Room 3
Fall risk assessment and prevention
Stefania Maggi
Meeting Room 4
Pharmacological management of osteoporosis in Poland
Edward Czerwinski
09.00 - 10.00
Poster Area
Poster Viewing Session III
09.00 - 10.00
Meeting Room 5
EDUCATIONAL LECTURE
How can behavioural sciences improve the outcome of daily practice? Daniel Pinto, Zachary Zenko
10.00 - 12.00
Auditorium B
SCIENTIFIC SESSION V
Chairpersons: René Rizzoli, Stefania Maggi
10.00
Auditorium B
Plenary Lecture 9
How to manage imminent fracture risk Thierry Thomas
10.30
Auditorium B
Presentation of the ESCEO-IOF Pierre Meunier Young Scientist Award
Bess Dawson‑Hughes
10.40
Auditorium B
Oral communications selected from abstracts
10.40
Auditorium B
OC35
‣ ASSESSING THE RISK OF OSTEOPOROSIS THROUGH RADIOFREQUENCY ECHOGRAPHIC MULTI SPECTROMETRY (REMS): RESULTS OF THE SCREENING CAMPAIGN IN THE ITALIAN POPULATION
Presenting author: L. Cianferotti
Authors: L. Cavalli, F. Giusti, G. Gronchi, C. Signorini, P. Pisani, M. L. Brandi
10.50
Auditorium B
OC36
‣ ADVANCED 3D REGISTRATION FOR MONITORING PERIPHERAL BMD AND BMC CHANGES IN GROWING BONES IN CHILDREN
Presenting author: K. Engelke
Authors: A. Friedberger, O. Museyko, H. Genant
11.00
Auditorium B
OC37
‣ CLUSTER ANALYSIS OF HIGH RESOLUTION PERIPHERAL QUANTITATIVE COMPUTED TOMOGRAPHY PARAMETERS IDENTIFIES BONE PHENOTYPES ASSOCIATED WITH HIGH RATES OF PREVALENT FRACTURE
Presenting author: M. H. Edwards
Authors: L. D. Westbury, C. Cooper, E. M. Dennison, K. A. Ward
11.20
Auditorium B
OC39
‣ ARTHRITIS ACROSS EDUCATION, INCOME AND RACE/ETHNICITY, AND THE MODERATING ROLE OF CHILDHOOD MALTREATMENT: DATA FROM THE NATIONAL EPIDEMIOLOGICAL SURVEY ON ALCOHOL AND RELATED CONDITIONS (NESARC)
Presenting author: S. Brennan‑Olsen
Authors: T.L. Taillieu, S. Turner, J. Bolton, S.E. Quirk, F. Gomez, R.L. Duckham, S.M. Hosking, G. Duque, D. Green, T.O. Afifi
11.30
Auditorium B
Plenary Lecture 10
Combined and sequential therapies in osteoporosis Michael R. McClung
12.00 - 13.00
NON-SPONSORED SYMPOSIA
Meeting Room 1
Management of Osteoporosis in Poland
Chairperson: Edward Czerwinski
The review of the 2017 updated polish guidelines for the diagnosis and management of osteoporosis Piotr Gluszko
Management of osteoporosis in poland: calcium and vitamin D Ewa Marcinowska‑Suchowierska
Rac-ost-pol – population based polish epidemiologic study on postmenopausal osteoporosis Wojciech Pluskiewicz
Value of T- and Z-scores in fracture prediction Przemyslax Borowy
Correlation between tbs, age and fracture in postmenopausal women Edward Czerwinski
Meeting Room 2
Physical activity and rehabilitation in osteoporosis and sarcopenia
Chairperson: Mark Lissens
Adapted physical activity using gerontechnology as the solution to counteract muscle function in frail population. Mylène Aubertin‑Leheudre
Rehabilitation of sarcopenic elderly Yannis Dionyssiottis
Correlation between sarcopenia and osteoporosis in patients with post poliomyelitis syndrome Mark Lissens
Meeting Room 3
Identification of vertebral fractures in Fracture Liaison Services in the UK
Chairperson: Kassim Javaid
The financial burden of vertebral fracture Tim Jones
Understanding the clinical guidance for the identification of vertebral fractures in the UK Sonya Stephenson
Meeting Room 6
Rational approach to osteoporosis in Turkey
Chairpersons: Berrin Durmaz, Sema Oncel
Approach of Turkish Physicians to Osteoporotic Vertebral Fractures Ozlen Peker
Hidden Problem: Osteoporotic Vertebral Fractures Yesim Gokce Kutsal
Medical Treatment of Osteoporosis Ozlem El
Orthoses and Exercises for Osteoporotic Vertebral Fractures Funda Calis
FRAX Study with Calcaneal Ultrasound in Turkish Postmenopausal Women Yesim Kirazli
Meeting Room 7
Autoimmune Sarcopenia
Chairperson: Mislav Radić
Autoimmune sarcopenia – current knowledge and perspective Mislav Radić
Risk of sarcopenia in rheumatoid arthritis patients Tonko Vlak
Risk of sarcopenia in systemic lupus erythematosus patients Miroslav Mayer
Meeting Room 5
Non-irradiating evaluation of bone mineral mass at peripheral and axial sites
Chairpersons: Maria Luisa Brandi, René Rizzoli
Non-irradiating osteoporosis diagnosis: Technologies description Francesco Conversano
An international clinical experience Adolfo Diez‑Perez
Symposium take home message Piotr Leszczynski
13.00
End of the Congress